Pharmaceutical manufacturing

FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study of volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
May 18, 2020 - 8:35 am
An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday. Study volunteers given either a low or medium dose of the vaccine by Cambridge, Massachusetts...
Read More
President Donald Trump speaks about the coronavirus in the Rose Garden of the White House, Friday, May 15, 2020, in Washington. Dr. Robert Redfield, director of the Centers for Disease Control and Prevention listens at left. (AP Photo/Alex Brandon)
May 15, 2020 - 1:39 pm
WASHINGTON (AP) — President Donald Trump vowed to use “every plane, truck and soldier” to distribute COVID-19 vaccines he hopes will be ready by year's end — even as the country's top scientists gear up for a master experiment to rapidly tell if any really work. Trump on Friday declared the vaccine...
Read More
Jason Antos, an Advanced EMT for Rescue Inc., puts a COVID-19 testing swab up the nasal passage of Anya Wolfe, of Wardsboro, Vt., during a pop-up COVID-19 testing clinic at the Brattleboro Union High School's parking lot in Brattleboro, Vt., Thursday, May 14, 2020. The clinics are part of the state's efforts to ramp up testing and prevent the spread of COVID-19. (Kristopher Radder/The Brattleboro Reformer via AP)
May 14, 2020 - 7:26 pm
SILVER SPRING, Md. (AP) — From a hospital on the edge of the Navajo Nation to the suburbs of the nation’s capital, front-line medical workers in coronavirus hot spots are struggling to keep up with a crushing load of patients while lockdown restrictions are lifting in many other parts of the U.S...
Read More
FILE - In this Feb. 7, 2019 the logo of French drug maker Sanofi is pictured at the company's headquarters, in Paris. French pharmaceutical group Sanofi ensured that it will make its COVID-19 vaccine, when ready, available in all countries, hours after the company's CEO said the United States will get first access. (AP Photo/Christophe Ena, File)
May 14, 2020 - 7:18 am
PARIS (AP) — French pharmaceutical group Sanofi promised Thursday that it would make its COVID-19 vaccine, when ready, available in all countries, hours after the company's CEO said the United States will get first access. Sanofi CEO Paul Hudson's comments that a vaccine would go first to the U.S...
Read More
FILE - In this March 16, 2020 file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. In a press briefing on Thursday May 14, 2020, the European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” (AP Photo/Ted S. Warren, File)
May 14, 2020 - 4:19 am
LONDON (AP) — The European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” Dr. Marco Cavaleri, who heads the European regulator’s vaccines department...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. America faces the “darkest winter in modern history” unless leaders act decisively to prevent a rebound of the coronavirus, says Bright, a government whistleblower who alleges he was ousted from his job for warning the Trump administration to prepare for the pandemic. (Health and Human Services via AP)
May 13, 2020 - 12:59 pm
WASHINGTON (AP) — America faces the “darkest winter in modern history” unless leaders act decisively to prevent a rebound of the coronavirus, says a government whistleblower who alleges he was ousted from his job for warning the Trump administration to prepare for the pandemic. Immunologist Dr...
Read More
FILE - In this Feb. 28, 2011, file photo, Director of research Judy Mikovits talks to a graduate student and research associate in the lab, at the Whittemore Peterson Institute for Neuro-Immune Disease, in Reno, Nev. Tech companies scrambled to take down a 26-minute documentary-style video called “Plandemic” of Mikovits promoting a string of questionable, false and potentially dangerous coronavirus theories. (David Calvert for AP Images, File)
May 12, 2020 - 4:56 pm
CHICAGO (AP) — One by one, tech companies across Silicon Valley scrambled to take down a slickly produced video of a discredited researcher peddling a variety of conspiracy theories about the coronavirus. It was all too late. The 26-minute documentary-style video dubbed “Plandemic,” in which anti-...
Read More
A health official wearing protective gear sprays disinfectant to help reduce the spread the new coronavirus ahead of school reopening in a cafeteria at a high school in Seoul, South Korea, Monday, May 11, 2020. (AP Photo/Lee Jin-man)
May 11, 2020 - 9:15 pm
The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. TOP OF THE HOUR: — South Korea reports 27 new coronavirus cases,...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
May 05, 2020 - 4:04 pm
WASHINGTON (AP) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint Tuesday. Dr. Rick Bright, former director of the Biomedical...
Read More
A worker of the Calzaturificio M.G.T shoe factory in Castelnuovo Vomano, central Italy, has her temperature checked at the entrance of the factory when she returns to work, Monday, May 4, 2020. Italy began stirring again Monday after a two-month coronavirus shutdown, with 4.4 million Italians able to return to work and restrictions on movement eased in the first European country to lock down in a bid to stem COVID-19 infections. (AP Photo/Domenico Stinellis)
Associated Press
May 04, 2020 - 7:59 pm
ROME (AP) — Italy started stirring Monday, with millions allowed back to work as Europe’s longest coronavirus lockdown started easing, while the U.S. took halting steps to lift some restrictions even as tens of thousands of new cases were reported daily. In Washington, the Senate convened for the...
Read More

Pages